Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort.
Bonelli GD, Sciascia S, Calatroni M, L'imperio V, Fenoglio R, Argolini LM, Carrara C, Lepori N, Reggiani F, Bortoluzzi A, Catapano F, Gatto M, Tani C, Longhitano E, Garozzo M, Trezzi B, Conte E, Santoro D, Gerosa M, Mosca M, Roccatello D, Sinico RA, Moroni G. Bonelli GD, et al. J Nephrol. 2025 Mar;38(2):643-653. doi: 10.1007/s40620-024-02178-1. Epub 2025 Jan 30. J Nephrol. 2025. PMID: 39883361
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study.
Gerosa M, Schioppo T, Argolini LM, Sciascia S, Ramirez GA, Moroni G, Sinico RA, Bonelli G, Alberici F, Mescia F, Moroni L, Tamborini F, Miraglia P, Bellocchi C, Beretta L, Roccatello D, Dagna L, Bozzolo E, Caporali R. Gerosa M, et al. Vaccines (Basel). 2022 Apr 22;10(5):663. doi: 10.3390/vaccines10050663. Vaccines (Basel). 2022. PMID: 35632419 Free PMC article.
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination.
Ramirez GA, Argolini LM, Schioppo T, Sciascia S, Moroni L, Moroni G, Sinico RA, Bonelli G, Alberici F, Mescia F, Tamborini F, Miraglia P, Bellocchi C, Beretta L, Roccatello D, Bozzolo EP, Caporali R, Gerosa M, Dagna L; SMILE, Milan Lupus Consortium. Ramirez GA, et al. Ann Rheum Dis. 2022 Sep 12;81(10):1476-1477. doi: 10.1136/ard-2022-222832. Ann Rheum Dis. 2022. PMID: 35922121 No abstract available.
Long-term kidney outcome of patients with rheumatological diseases and antineutrophil cytoplasmic antibody-glomerulonephritis: comparison with a primitive ANCA-glomerulonephritis cohort.
Locatelli L, Calatroni M, Reggiani F, Bonelli GD, Gerosa M, Argolini LM, Trezzi B, Del Papa N, Angelini C, Pozzi MR, Sinico RA, Moroni G. Locatelli L, et al. Among authors: bonelli gd. Clin Exp Rheumatol. 2023 Apr;41(4):856-863. doi: 10.55563/clinexprheumatol/csk834. Epub 2022 Dec 19. Clin Exp Rheumatol. 2023. PMID: 36533986 Free article.
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis.
Gatto M, Frontini G, Calatroni M, Reggiani F, Depascale R, Cruciani C, Quaglini S, Sacchi L, Trezzi B, Bonelli GD, L'Imperio V, Vaglio A, Furlan C, Zen M, Iaccarino L, Sinico RA, Doria A, Moroni G. Gatto M, et al. Among authors: bonelli gd. Kidney Int Rep. 2024 Jan 19;9(4):1047-1056. doi: 10.1016/j.ekir.2024.01.016. eCollection 2024 Apr. Kidney Int Rep. 2024. PMID: 38765576 Free PMC article.
Corrigendum to "Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis" [Kidney International Reports Volume 9, Issue 4, April 2024, Pages 1047-1056].
Gatto M, Frontini G, Calatroni M, Reggiani F, Depascale R, Cruciani C, Quaglini S, Sacchi L, Trezzi B, Bonelli GD, L'Imperio V, Vaglio A, Furlan C, Zen M, Iaccarino L, Sinico RA, Doria A, Moroni G. Gatto M, et al. Among authors: bonelli gd. Kidney Int Rep. 2024 Feb 24;9(4):1143. doi: 10.1016/j.ekir.2024.02.1399. eCollection 2024 Apr. Kidney Int Rep. 2024. PMID: 38765595 Free PMC article.
Different clusters in patients with lupus podocytopathy identified by clinical-pathological characteristics.
Sciascia S, Bonelli GD, Calatroni M, L'imperio V, Fenoglio R, Argolini LM, Carrara C, Lepori N, Reggiani F, Bortoluzzi A, Catapano F, Gatto M, Tani C, Longhitano E, Garozzo M, Trezzi B, Conte E, Santoro D, Gerosa M, Mosca M, Sinico RA, Moroni G, Roccatello D. Sciascia S, et al. Among authors: bonelli gd. Minerva Urol Nephrol. 2025 Apr;77(2):159-161. doi: 10.23736/S2724-6051.25.06306-2. Epub 2025 Mar 7. Minerva Urol Nephrol. 2025. PMID: 40052259 Free article. No abstract available.
Long Term Outcomes of Anti-COVID-19 Vaccines in Patients with Systemic Lupus Erythematosus: A Multicentre Study.
Benanti G, Ramirez GA, Schioppo T, Argolini LM, Moroni G, Bonelli G, Sinico RA, Alberici F, Mescia F, Moroni L, Gallina GD, Venerandi B, Tamborini F, Bellocchi C, Beretta L, Caporali R, Bozzolo E, Dagna L, Gerosa M. Benanti G, et al. Among authors: bonelli g. Vaccines (Basel). 2025 Jul 8;13(7):735. doi: 10.3390/vaccines13070735. Vaccines (Basel). 2025. PMID: 40733712 Free PMC article.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.